Kairos Pharma CEO on Phase 2 Safety Data, 165% Stock Move & September Efficacy Timeline

By CEO.CA / July 25, 2025 / www.youtube.com / Article Link

We caught up with Dr. John Yu, CEO of Kairos Pharma, Ltd. (NYSE American: KAPA) to discuss the company's safety data ...

Recent News

Gold stocks down as markets continue to new highs

July 21, 2025 / www.canadianminingreport.com

TSXV Top 20 Gold market cap shifts away from exploration

July 21, 2025 / www.canadianminingreport.com

Many new players enter TSXV gold Top 25 by market cap

July 14, 2025 / www.canadianminingreport.com

Gold stocks mixed on moderate metal gain, flat equities

July 14, 2025 / www.canadianminingreport.com

Gold stocks lead the large cap miners by far over H1/25

July 07, 2025 / www.canadianminingreport.com

See all >